Drug reference

pirfenidone

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1058

Overview

Names and pronunciation

(pir-fen′i-done) Esbriet

PDF page 1058

Functional class

Func. class.: Respiratory agent

PDF page 1058

Uses

USES: Pulmonary fibrosis

PDF page 1058

Safety

Contraindications

CONTRAINDICATIONS: Hyper sensitivity

PDF page 1058

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult: PO 267 mg tid on days 1-7, 534 mg tid on days 8-14, and 801 mg tid from day 15 onward

PDF page 1058

Available forms

Available forms: Capsule 267 mg; tabs 267, 801 mg

PDF page 1058

Dose text by age group

Adult

• Adult: PO 267 mg tid on days 1-7, 534 mg tid on days 8-14, and 801 mg tid from day 15 onward

PDF page 1058

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

pirfenidone

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1058

Overview

Names and pronunciation

(pir-fen′i-done) Esbriet

PDF page 1058

Functional class

Func. class.: Respiratory agent

PDF page 1058

Uses

USES: Pulmonary fibrosis

PDF page 1058

Safety

Contraindications

CONTRAINDICATIONS: Hyper sensitivity

PDF page 1058

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Adult: PO 267 mg tid on days 1-7, 534 mg tid on days 8-14, and 801 mg tid from day 15 onward

PDF page 1058

Available forms

Available forms: Capsule 267 mg; tabs 267, 801 mg

PDF page 1058

Dose text by age group

Adult

• Adult: PO 267 mg tid on days 1-7, 534 mg tid on days 8-14, and 801 mg tid from day 15 onward

PDF page 1058

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.